BOBanke Oketola

Banke Oketola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Banke Oketola has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Harminder Singh

    Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada

    2 shared publications
  • Adam Rapoport

    Paediatric Advanced Care Team Hospital for Sick Children Toronto Ontario Canada

    1 shared publication
  • Ahmed M Abou-Setta

    Department of Internal Medicine, George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba , Winnipeg, Manitoba , Canada

    1 shared publication
  • Allison B. Dart

    University of Manitoba, Winnipeg, Manitoba, Canada

    1 shared publication
  • Autumn Neville

    Centre for Outcomes Research and Evaluation, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

    1 shared publication
  • Claire Adams

    Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada

    1 shared publication

Latest Publications

  • Open Access

    Implementation of a Novel Patient-Reported Outcome Measure for the Assessment of Symptoms in Children Living With Chronic Kidney Disease (PRO-Kid)—Program Report

    by Banke Oketola, Karma Abukasm, Ke Fan Bei, Kelly Loverock, Kim Widger, Valerie Umaefulam, Leanne Dunne, Sarah Kirby, Rahul Chanchlani, Claire Adams, et al.

    Purpose of the Program: Children with chronic kidney disease (CKD) experience significant physical and psychological symptoms, necessitating patient-reported outcome (PRO) measurement tools to quantify symptoms, and to improve communication between children with CKD and their health care providers. This study aimed to implement the novel PRO-Kid tool into pediatric CKD and dialysis programs in Canada. Sources of Information: The PRO-Kid tool is a novel 14-item questionnaire that was developed and validated by our research team, in partnership with patients living with childhood-onset CKD and caregivers for children with G3-G5 CKD, including dialysis. PRO-Kid measures both the frequency and impact of CKD symptoms in children ages eight to 18 years. It showed strong internal consistency and validity, as demonstrated by a Cronbach alpha of .83 (95% confidence interval [CI], 0.78-0.88) for the frequency scale, and .84 (95% CI, 0.80-0.89) on the impact scale. Methods: The PRO-Kid tool is being implemented in seven Pediatric Nephrology Programs across Canada. Guided by the Consolidated Framework for Implementation Research (CFIR), organizational readiness at each of the sites was assessed via surveys and focus groups. To date, the PRO-Kid tool (eight- to 18-year-old version) and site-specific toolkits have been implemented at three sites that were ready to launch (HSC, Winnipeg; BC Children’s Hospital, Vancouver; and McMaster Children’s Hospital, Hamilton). Implementation outcomes, such as the number of patients reached and patient and provider satisfaction, were evaluated using audits, surveys, and focus groups guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Key Findings: The organizational readiness assessment identified different electronic medical records and preferences for paper-based data collection methods across sites as well as the need to translate the PRO-Kid tool into other languages. Preliminary evaluation revealed that PRO-Kid is easy to use and is satisfactory to both patients and health care providers. Local champions were identified as key facilitators of implementation efforts. PRO-Kid can help improve communication between children with CKD and their health care providers in identifying symptoms that may not otherwise come up (be disclosed) during clinical encounters. However, language and low reading levels are barriers for some children, and unavailability of clinical staff can limit the use of the tool at some sites. Implications: Local teams will be required to play crucial roles in integrating the use of the tool in clinical settings. To ensure the tool can be applied across diverse populations, the validation of PRO-Kid tool two to four years old, five to seven years old, and French versions are ongoing. The availability of different versions of the tool will ensure equitable access and promote sustainability of the tool.


  • Open Access

    Behaviour Change Considerations to Promote Physical Activity Participation among Individuals with Quiescent Inflammatory Bowel Disease: Barriers and Facilitators

    by Banke Oketola, Sandra Webber, Harminder Singh, Maia Kredentser, Kristin Reynolds, Gayle Restall

    Background: Most individuals with inflammatory bowel diseases (IBD) do not engage in optimum levels of physical activity (PA). This study aimed to identify important factors to consider when promoting PA participation among individuals with quiescent or mildly active IBD. Methods: In this qualitative description study, we purposively enrolled 15 Manitobans with quiescent IBD. Data was collected via semi-structured interviews conducted on Zoom. Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) model, we elicited factors that influence PA behaviour. We performed thematic analysis of transcribed interviews using NVivo. Results: Participants’ (N = 15) ages ranged between 20 and 37 years, majority were female (n = 8), and most had a diagnosis of ulcerative colitis (UC) (n = 10). None was a current smoker. Thematic analysis identified persistent symptoms, PA engagement prior to IBD diagnosis, PA routine, coping strategies and determination as themes that influenced ‘capability’ for PA participation. Social support, type of employment, bathroom access, and finances influenced ‘opportunity’. Awareness of the benefits of PA on IBD, relevant knowledge, social support, and personal goals promoted ‘motivation’ for PA participation. Sex differences were noted in participants’ perspectives related to safety concerns and the social context of workout spaces. Conclusion: Using the COM-B model, we elicited barriers (including IBD-related persistent symptoms, lack of knowledge of PA) and facilitators (social support, coping strategies, ability to track PA progress) that influence PA behaviour among adults with quiescent IBD. These factors are important considerations when promoting PA participation among individuals with IBD.


  • Open Access

    Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar Anti–tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-world Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC Registry

    by Banke Oketola, Sasha Bernatsky, Luck Lukusa, Cristiano S. Moura, Autumn Neville, Yvette Leung, Neeraj Narula, Waqqas Afif, Marina G. Birck, Petros Zezos, et al.

  • Open Access

    Physical Activity for Quiescent and Mildly Active Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

    by Banke Oketola, Olayinka Akinrolie, Sandra Webber, Nicole Askin, Rasheda Rabbani, Ahmed M Abou-Setta, Harminder Singh

    Background: Physical activity (PA) may benefit people with inflammatory bowel diseases (IBD) by improving immunological response, musculoskeletal function, and psychological health. Aims: We distilled available evidence on the efficacy and safety of PA to improve health-related quality of life (HRQoL) and relieve persistent symptoms of fatigue, joint pain, abdominal pain, stress, anxiety, and depression in individuals with quiescent/mild IBD. Methods: We searched for trials in eight databases and trial registries. Trials using PA as an adjunct therapy in the management of adults (≥18 years) with quiescent or mild IBD, published in English between 2011 and 2023 were identified. Summary effect estimates were expressed as standardized mean difference (SMD) or mean difference (MD) with 95% confidence interval (CI) using random-effects model. Results: From the 10,862 citations retrieved, we included seven randomized controlled trials (RCTs) and one non-RCT. There was no evidence of benefit of PA on HRQoL (SMD 0.34, 95%CI −0.08 to 0.77; I2 57%); high heterogeneity was noted among included trials. PA was found to be efficacious in reducing anxiety (SMD −0.35, 95%CI −0.65 to −0.05; I2 0%). There was insufficient evidence to make conclusions regarding changes in fatigue, joint pain, abdominal pain, stress, and depression. All trials deemed physical activity safe. Conclusions: PA contributes to reducing anxiety in quiescent/mild IBD. There is marked heterogeneity in methodology among trials investigating PA in adults with quiescent/mild IBD. This review highlights the need for consistent definitions of PA types and intensities in this field of research.